Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $194 to $225.
Goldman Sachs analyst Scott Fidel assumes Tenet Healthcare (NYSE:THC) with a Buy rating and announces Price Target of $224.
Keybanc analyst Scott Schoenhaus maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $2...
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from ...
Cantor Fitzgerald analyst Sarah James reiterates Tenet Healthcare (NYSE:THC) with a Overweight and maintains $190 price target.
